

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.60482640 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.08150292 |
| 3 | * regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.04181964 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.91422899 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.74239648 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.69741064 |
| 7 | glutamate secretion (GO:0014047) | 5.66332689 |
| 8 | vocalization behavior (GO:0071625) | 5.53891891 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.41748206 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.30705002 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.20408407 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89013317 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.87345091 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.86309652 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.83771848 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.67974374 |
| 17 | exploration behavior (GO:0035640) | 4.65343592 |
| 18 | protein localization to synapse (GO:0035418) | 4.64937635 |
| 19 | layer formation in cerebral cortex (GO:0021819) | 4.44847240 |
| 20 | gamma-aminobutyric acid transport (GO:0015812) | 4.39913478 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.39657062 |
| 22 | proline transport (GO:0015824) | 4.36600795 |
| 23 | amino acid import (GO:0043090) | 4.36239650 |
| 24 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.34046818 |
| 25 | potassium ion homeostasis (GO:0055075) | 4.33886638 |
| 26 | regulation of synapse structural plasticity (GO:0051823) | 4.30495176 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.29598294 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.23904039 |
| 29 | sodium ion export (GO:0071436) | 4.23258501 |
| 30 | regulation of synapse maturation (GO:0090128) | 4.21167019 |
| 31 | * regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.17524930 |
| 32 | glutamate receptor signaling pathway (GO:0007215) | 4.13284562 |
| 33 | positive regulation of dendritic spine development (GO:0060999) | 4.12060798 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.02363360 |
| 35 | long-term memory (GO:0007616) | 4.00964281 |
| 36 | central nervous system myelination (GO:0022010) | 4.00784153 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 4.00784153 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98269756 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 3.98169455 |
| 40 | neurotransmitter transport (GO:0006836) | 3.95462922 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.93753651 |
| 42 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.91884907 |
| 43 | activation of protein kinase A activity (GO:0034199) | 3.83583751 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.82814295 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.77657572 |
| 46 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.77637610 |
| 47 | neuromuscular process controlling posture (GO:0050884) | 3.77033525 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.69165101 |
| 49 | neuromuscular process controlling balance (GO:0050885) | 3.67363636 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.66890589 |
| 51 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.65742686 |
| 52 | regulation of neurotransmitter levels (GO:0001505) | 3.64759301 |
| 53 | synaptic vesicle endocytosis (GO:0048488) | 3.62889938 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.62475765 |
| 55 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.61409101 |
| 56 | cellular sodium ion homeostasis (GO:0006883) | 3.59943209 |
| 57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.59516998 |
| 58 | glycine transport (GO:0015816) | 3.56561550 |
| 59 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.51907205 |
| 60 | dendritic spine organization (GO:0097061) | 3.51542977 |
| 61 | * regulation of synaptic plasticity (GO:0048167) | 3.49486918 |
| 62 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.48594537 |
| 63 | cell communication by electrical coupling (GO:0010644) | 3.43855286 |
| 64 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.42766891 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.42699537 |
| 66 | neurotransmitter uptake (GO:0001504) | 3.42284208 |
| 67 | transmission of nerve impulse (GO:0019226) | 3.41747891 |
| 68 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41528056 |
| 69 | vesicle docking involved in exocytosis (GO:0006904) | 3.39528804 |
| 70 | regulation of dendritic spine development (GO:0060998) | 3.37374281 |
| 71 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.36240124 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 3.34058509 |
| 73 | acidic amino acid transport (GO:0015800) | 3.31937347 |
| 74 | membrane depolarization during action potential (GO:0086010) | 3.31700957 |
| 75 | synaptic vesicle transport (GO:0048489) | 3.31228447 |
| 76 | establishment of synaptic vesicle localization (GO:0097480) | 3.31228447 |
| 77 | long-term synaptic potentiation (GO:0060291) | 3.31171251 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.30857861 |
| 79 | neuron recognition (GO:0008038) | 3.30554941 |
| 80 | cerebellar Purkinje cell layer development (GO:0021680) | 3.28180393 |
| 81 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.26705497 |
| 82 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26590918 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.25740667 |
| 84 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.25208646 |
| 85 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.25016565 |
| 86 | cell differentiation in hindbrain (GO:0021533) | 3.24749277 |
| 87 | neuromuscular synaptic transmission (GO:0007274) | 3.24624100 |
| 88 | auditory behavior (GO:0031223) | 3.23812242 |
| 89 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.23331954 |
| 90 | vesicle transport along microtubule (GO:0047496) | 3.23003836 |
| 91 | response to auditory stimulus (GO:0010996) | 3.21803960 |
| 92 | prepulse inhibition (GO:0060134) | 3.21061831 |
| 93 | membrane depolarization (GO:0051899) | 3.18811475 |
| 94 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.18529718 |
| 95 | establishment of mitochondrion localization (GO:0051654) | 3.15863780 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.14679719 |
| 97 | L-amino acid import (GO:0043092) | 3.12548384 |
| 98 | membrane hyperpolarization (GO:0060081) | 3.10605091 |
| 99 | regulation of ARF protein signal transduction (GO:0032012) | 3.10372684 |
| 100 | dendrite morphogenesis (GO:0048813) | 3.10242920 |
| 101 | potassium ion import (GO:0010107) | 3.09575247 |
| 102 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08681797 |
| 103 | regulation of exocytosis (GO:0017157) | 3.07914876 |
| 104 | vesicle docking (GO:0048278) | 3.07740888 |
| 105 | cerebellar granule cell differentiation (GO:0021707) | 3.06776067 |
| 106 | neuromuscular process (GO:0050905) | 3.05810137 |
| 107 | synaptic transmission (GO:0007268) | 3.03935358 |
| 108 | intraspecies interaction between organisms (GO:0051703) | 3.03537648 |
| 109 | social behavior (GO:0035176) | 3.03537648 |
| 110 | neuronal ion channel clustering (GO:0045161) | 3.02711486 |
| 111 | postsynaptic membrane organization (GO:0001941) | 3.02259144 |
| 112 | axonal fasciculation (GO:0007413) | 3.01737265 |
| 113 | positive regulation of synaptic transmission (GO:0050806) | 3.00685095 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00365042 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99745197 |
| 116 | * regulation of synaptic transmission (GO:0050804) | 2.98261192 |
| 117 | learning (GO:0007612) | 2.97523264 |
| 118 | innervation (GO:0060384) | 2.96410116 |
| 119 | mating behavior (GO:0007617) | 2.96083528 |
| 120 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.93755211 |
| 121 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93623892 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93620338 |
| 123 | synapse assembly (GO:0007416) | 2.93045147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.09847407 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17133363 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10879269 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08097771 |
| 5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.05006841 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05002452 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.91797047 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80640225 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80640225 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.78632908 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68043707 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63674609 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63056529 |
| 14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.56372422 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55954045 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47033415 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44322991 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40253346 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.39735539 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.37240065 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31754515 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29958711 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26965337 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.23014160 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19652152 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.16595590 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13086244 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91369772 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.90770509 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70736255 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.63429623 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57468761 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.56136674 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55464857 |
| 35 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.53944382 |
| 36 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51995001 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51403505 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49052570 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48367051 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42372090 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38224408 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33380783 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33354286 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.32770775 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32734198 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30620101 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30440422 |
| 48 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30249065 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30228610 |
| 50 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29469317 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27782216 |
| 52 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.25601037 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24827761 |
| 54 | AR_19668381_ChIP-Seq_PC3_Human | 1.23534903 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22828270 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21525750 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20772696 |
| 58 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.18521726 |
| 59 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16981855 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15861976 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15409855 |
| 62 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.14851917 |
| 63 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13409177 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13265905 |
| 65 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.12632281 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11615217 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11602248 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10716208 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10649396 |
| 70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08689848 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08544384 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06666399 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06461614 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03818723 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02498633 |
| 76 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02260761 |
| 77 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02042862 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99897790 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99713137 |
| 80 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.98051059 |
| 81 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97775507 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97616250 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97003630 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96750076 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96045940 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95969813 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95274343 |
| 88 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95100972 |
| 89 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94815455 |
| 90 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94720037 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94460219 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94266387 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93934790 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93894630 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93441230 |
| 96 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.93239054 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92801900 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92516333 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92132461 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90803821 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90294334 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89938100 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87016705 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86149817 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85965263 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84373972 |
| 107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83604196 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83082235 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82737169 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82383526 |
| 111 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.82265376 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81980847 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81845788 |
| 114 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81819799 |
| 115 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.81784392 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81561164 |
| 117 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.80808151 |
| 118 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80626791 |
| 119 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80552019 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79655898 |
| 121 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79351142 |
| 122 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79063258 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.78773169 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.78530634 |
| 125 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77806166 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77612646 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76791525 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76780396 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.76065914 |
| 130 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.75340660 |
| 131 | SA1_27219007_Chip-Seq_Bcells_Human | 0.74056391 |
| 132 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73750553 |
| 133 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73374000 |
| 134 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.72995748 |
| 135 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69997638 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68549360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0004859_abnormal_synaptic_plasticity | 6.51697630 |
| 2 | MP0003880_abnormal_central_pattern | 4.61406114 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.26865385 |
| 4 | MP0004270_analgesia | 3.79526999 |
| 5 | MP0009745_abnormal_behavioral_response | 3.46629246 |
| 6 | MP0009046_muscle_twitch | 3.46159114 |
| 7 | MP0002064_seizures | 3.34730447 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.32544898 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.14556987 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.99179070 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.78752913 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.78567656 |
| 13 | MP0002822_catalepsy | 2.70367812 |
| 14 | MP0002272_abnormal_nervous_system | 2.69651643 |
| 15 | MP0001486_abnormal_startle_reflex | 2.52335554 |
| 16 | MP0002736_abnormal_nociception_after | 2.38868479 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.34510912 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.23791422 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.20476998 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.15691116 |
| 21 | MP0008569_lethality_at_weaning | 2.14374181 |
| 22 | MP0001970_abnormal_pain_threshold | 2.08581863 |
| 23 | MP0004858_abnormal_nervous_system | 2.05159053 |
| 24 | MP0003329_amyloid_beta_deposits | 2.04584942 |
| 25 | MP0002067_abnormal_sensory_capabilities | 2.02589564 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.97605621 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.83421181 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.83251604 |
| 29 | MP0002184_abnormal_innervation | 1.78747116 |
| 30 | MP0004924_abnormal_behavior | 1.78580375 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.78580375 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.70387404 |
| 33 | MP0003879_abnormal_hair_cell | 1.65561321 |
| 34 | MP0000955_abnormal_spinal_cord | 1.57430579 |
| 35 | MP0000778_abnormal_nervous_system | 1.55007288 |
| 36 | MP0004885_abnormal_endolymph | 1.54364883 |
| 37 | MP0003123_paternal_imprinting | 1.53149476 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.51440090 |
| 39 | MP0002066_abnormal_motor_capabilities/c | 1.47356169 |
| 40 | MP0003633_abnormal_nervous_system | 1.46028398 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.43467310 |
| 42 | MP0001984_abnormal_olfaction | 1.42817722 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.42348648 |
| 44 | MP0004147_increased_porphyrin_level | 1.40151862 |
| 45 | MP0004142_abnormal_muscle_tone | 1.30586442 |
| 46 | MP0003787_abnormal_imprinting | 1.24979880 |
| 47 | MP0003631_nervous_system_phenotype | 1.23610855 |
| 48 | MP0000751_myopathy | 1.19393984 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.18487705 |
| 50 | MP0001905_abnormal_dopamine_level | 1.17764832 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.17716978 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.12866931 |
| 53 | MP0008872_abnormal_physiological_respon | 1.11111884 |
| 54 | MP0002229_neurodegeneration | 1.10253434 |
| 55 | MP0003122_maternal_imprinting | 1.07190134 |
| 56 | MP0002152_abnormal_brain_morphology | 1.07174434 |
| 57 | MP0001529_abnormal_vocalization | 1.06426039 |
| 58 | MP0003283_abnormal_digestive_organ | 1.02908222 |
| 59 | MP0003690_abnormal_glial_cell | 1.01844051 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 0.98649554 |
| 61 | MP0000569_abnormal_digit_pigmentation | 0.98169959 |
| 62 | MP0000604_amyloidosis | 0.97339051 |
| 63 | MP0003634_abnormal_glial_cell | 0.94514041 |
| 64 | MP0003075_altered_response_to | 0.94435792 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.94287241 |
| 66 | MP0003632_abnormal_nervous_system | 0.93625468 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.93161366 |
| 68 | MP0008874_decreased_physiological_sensi | 0.92936940 |
| 69 | MP0002069_abnormal_eating/drinking_beha | 0.91642778 |
| 70 | MP0003172_abnormal_lysosome_physiology | 0.87531246 |
| 71 | MP0005535_abnormal_body_temperature | 0.86265280 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.85842133 |
| 73 | MP0000920_abnormal_myelination | 0.85519080 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.85443675 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.85321414 |
| 76 | MP0002090_abnormal_vision | 0.84593065 |
| 77 | MP0001177_atelectasis | 0.83766828 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.83374773 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.82836187 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.82654939 |
| 81 | MP0004085_abnormal_heartbeat | 0.82051831 |
| 82 | MP0004742_abnormal_vestibular_system | 0.80461413 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.77553755 |
| 84 | MP0004484_altered_response_of | 0.76937715 |
| 85 | MP0005499_abnormal_olfactory_system | 0.76592861 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.76592861 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.75307701 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.74165645 |
| 89 | MP0004233_abnormal_muscle_weight | 0.71938744 |
| 90 | MP0004510_myositis | 0.71235844 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.70575981 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.70439724 |
| 93 | MP0002752_abnormal_somatic_nervous | 0.70302258 |
| 94 | MP0000747_muscle_weakness | 0.64590182 |
| 95 | MP0003646_muscle_fatigue | 0.63970897 |
| 96 | MP0004043_abnormal_pH_regulation | 0.63274301 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.63185735 |
| 98 | MP0003121_genomic_imprinting | 0.62635822 |
| 99 | MP0001188_hyperpigmentation | 0.62184991 |
| 100 | MP0000579_abnormal_nail_morphology | 0.60309791 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.58120079 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.56142392 |
| 103 | MP0010768_mortality/aging | 0.55886978 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.54156129 |
| 105 | MP0001664_abnormal_digestion | 0.54145789 |
| 106 | MP0010769_abnormal_survival | 0.53962227 |
| 107 | MP0002082_postnatal_lethality | 0.53632978 |
| 108 | MP0010770_preweaning_lethality | 0.53632978 |
| 109 | MP0004130_abnormal_muscle_cell | 0.53618054 |
| 110 | MP0003956_abnormal_body_size | 0.51497692 |
| 111 | MP0001943_abnormal_respiration | 0.51487608 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.50111781 |
| 113 | MP0005171_absent_coat_pigmentation | 0.49600126 |
| 114 | MP0002249_abnormal_larynx_morphology | 0.48453074 |
| 115 | MP0003861_abnormal_nervous_system | 0.47334459 |
| 116 | MP0002873_normal_phenotype | 0.46502717 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.44832224 |
| 118 | MP0002169_no_abnormal_phenotype | 0.44669120 |
| 119 | MP0000026_abnormal_inner_ear | 0.43167146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.45564569 |
| 2 | Myokymia (HP:0002411) | 7.13032209 |
| 3 | Visual hallucinations (HP:0002367) | 5.89571897 |
| 4 | Focal seizures (HP:0007359) | 5.84384142 |
| 5 | Atonic seizures (HP:0010819) | 4.69623082 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.64569621 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.55480204 |
| 8 | Action tremor (HP:0002345) | 4.46692845 |
| 9 | Febrile seizures (HP:0002373) | 4.42877980 |
| 10 | Absence seizures (HP:0002121) | 4.23710445 |
| 11 | Cerebral hypomyelination (HP:0006808) | 4.13605015 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.96905706 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.96748847 |
| 14 | Dialeptic seizures (HP:0011146) | 3.85269585 |
| 15 | Ankle clonus (HP:0011448) | 3.71927554 |
| 16 | Obstructive sleep apnea (HP:0002870) | 3.51591085 |
| 17 | Depression (HP:0000716) | 3.50524332 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.48105474 |
| 19 | Poor eye contact (HP:0000817) | 3.46031354 |
| 20 | Mutism (HP:0002300) | 3.43956671 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.36189854 |
| 22 | Broad-based gait (HP:0002136) | 3.35881328 |
| 23 | Postural instability (HP:0002172) | 3.27136382 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.26395745 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.20955867 |
| 26 | Abnormal social behavior (HP:0012433) | 3.20085256 |
| 27 | Impaired social interactions (HP:0000735) | 3.20085256 |
| 28 | Dysmetria (HP:0001310) | 3.15745106 |
| 29 | Papilledema (HP:0001085) | 3.14016687 |
| 30 | Abnormality of the lower motor neuron (HP:0002366) | 3.10919885 |
| 31 | Truncal ataxia (HP:0002078) | 3.08479377 |
| 32 | Anxiety (HP:0000739) | 3.08087311 |
| 33 | Abnormal eating behavior (HP:0100738) | 3.05528010 |
| 34 | Akinesia (HP:0002304) | 2.99766252 |
| 35 | Ventricular fibrillation (HP:0001663) | 2.99734208 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.90612844 |
| 37 | Genetic anticipation (HP:0003743) | 2.83339425 |
| 38 | Hemiplegia (HP:0002301) | 2.78763830 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.75903715 |
| 40 | Diplopia (HP:0000651) | 2.75903715 |
| 41 | Intention tremor (HP:0002080) | 2.75702159 |
| 42 | Urinary urgency (HP:0000012) | 2.75221539 |
| 43 | Amblyopia (HP:0000646) | 2.74961064 |
| 44 | Progressive inability to walk (HP:0002505) | 2.70197120 |
| 45 | Bradykinesia (HP:0002067) | 2.68503640 |
| 46 | Hemiparesis (HP:0001269) | 2.65354883 |
| 47 | Spastic gait (HP:0002064) | 2.63301516 |
| 48 | Dysmetric saccades (HP:0000641) | 2.62189423 |
| 49 | Sleep apnea (HP:0010535) | 2.62011460 |
| 50 | Scanning speech (HP:0002168) | 2.61803801 |
| 51 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.59521657 |
| 52 | Torticollis (HP:0000473) | 2.58430194 |
| 53 | Pheochromocytoma (HP:0002666) | 2.56401609 |
| 54 | Hyperventilation (HP:0002883) | 2.53164818 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.52892914 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.51984232 |
| 57 | CNS hypomyelination (HP:0003429) | 2.51747220 |
| 58 | Status epilepticus (HP:0002133) | 2.50490765 |
| 59 | Diminished motivation (HP:0000745) | 2.48788148 |
| 60 | Focal dystonia (HP:0004373) | 2.44018691 |
| 61 | Bundle branch block (HP:0011710) | 2.43872377 |
| 62 | Annular pancreas (HP:0001734) | 2.42243583 |
| 63 | Drooling (HP:0002307) | 2.39266631 |
| 64 | Excessive salivation (HP:0003781) | 2.39266631 |
| 65 | Choreoathetosis (HP:0001266) | 2.37766357 |
| 66 | Stereotypic behavior (HP:0000733) | 2.34591068 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.32947390 |
| 68 | Limb dystonia (HP:0002451) | 2.28820977 |
| 69 | Spastic tetraparesis (HP:0001285) | 2.27705798 |
| 70 | Abnormality of the corticospinal tract (HP:0002492) | 2.27075646 |
| 71 | Termporal pattern (HP:0011008) | 2.26967841 |
| 72 | Insidious onset (HP:0003587) | 2.26967841 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.25986707 |
| 74 | Impaired vibratory sensation (HP:0002495) | 2.22653697 |
| 75 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22090700 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.20865058 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 2.19243336 |
| 78 | Neuroendocrine neoplasm (HP:0100634) | 2.18104209 |
| 79 | Megalencephaly (HP:0001355) | 2.16354970 |
| 80 | Craniofacial dystonia (HP:0012179) | 2.15241382 |
| 81 | Insomnia (HP:0100785) | 2.14435403 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.13717297 |
| 83 | Agitation (HP:0000713) | 2.13092218 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.12559037 |
| 85 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11401545 |
| 86 | Polyphagia (HP:0002591) | 2.07291917 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06762686 |
| 88 | Unsteady gait (HP:0002317) | 2.06495476 |
| 89 | Rapidly progressive (HP:0003678) | 2.06420733 |
| 90 | Clonus (HP:0002169) | 2.04737831 |
| 91 | Rigidity (HP:0002063) | 2.04477092 |
| 92 | Pointed chin (HP:0000307) | 2.03856492 |
| 93 | Delusions (HP:0000746) | 2.03351236 |
| 94 | Absent speech (HP:0001344) | 2.02308282 |
| 95 | Inability to walk (HP:0002540) | 2.00337811 |
| 96 | Gait ataxia (HP:0002066) | 2.00258505 |
| 97 | Spinal canal stenosis (HP:0003416) | 1.99789194 |
| 98 | Abnormality of saccadic eye movements (HP:0000570) | 1.99611395 |
| 99 | Resting tremor (HP:0002322) | 1.98320131 |
| 100 | Tetraplegia (HP:0002445) | 1.97182008 |
| 101 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.95442983 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.95442983 |
| 103 | Abnormal EKG (HP:0003115) | 1.92776480 |
| 104 | Incomplete penetrance (HP:0003829) | 1.91980998 |
| 105 | Apathy (HP:0000741) | 1.89854688 |
| 106 | Psychosis (HP:0000709) | 1.89582771 |
| 107 | Iris hypopigmentation (HP:0007730) | 1.88346052 |
| 108 | Postural tremor (HP:0002174) | 1.87720111 |
| 109 | Lower limb amyotrophy (HP:0007210) | 1.87698004 |
| 110 | Peripheral hypomyelination (HP:0007182) | 1.87384494 |
| 111 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.87365892 |
| 112 | Failure to thrive in infancy (HP:0001531) | 1.86990428 |
| 113 | Lower limb asymmetry (HP:0100559) | 1.84569886 |
| 114 | Ocular albinism (HP:0001107) | 1.83121101 |
| 115 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82060551 |
| 116 | Blue irides (HP:0000635) | 1.79792425 |
| 117 | Memory impairment (HP:0002354) | 1.78968297 |
| 118 | Aplasia involving bones of the extremities (HP:0009825) | 1.78745545 |
| 119 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.78745545 |
| 120 | Aplasia of the phalanges of the hand (HP:0009802) | 1.78745545 |
| 121 | Dementia (HP:0000726) | 1.75036752 |
| 122 | Heart block (HP:0012722) | 1.73331073 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.72550473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.33755589 |
| 2 | NTRK3 | 4.22282188 |
| 3 | EPHA4 | 3.82082974 |
| 4 | MAP3K4 | 3.04422646 |
| 5 | MARK1 | 2.92607092 |
| 6 | MINK1 | 2.77574441 |
| 7 | DAPK2 | 2.74851228 |
| 8 | PAK6 | 2.48796161 |
| 9 | MAP2K7 | 2.40368525 |
| 10 | KSR2 | 2.33779948 |
| 11 | CAMKK1 | 2.16054062 |
| 12 | PRKD3 | 2.15765966 |
| 13 | NTRK1 | 2.13825955 |
| 14 | NTRK2 | 2.04450524 |
| 15 | MAP2K4 | 1.99013925 |
| 16 | MAP3K12 | 1.95025237 |
| 17 | RIPK4 | 1.89437269 |
| 18 | GRK5 | 1.67300378 |
| 19 | STK38 | 1.60910482 |
| 20 | DAPK1 | 1.58489965 |
| 21 | CDK5 | 1.56119779 |
| 22 | ARAF | 1.51123737 |
| 23 | CAMKK2 | 1.46197067 |
| 24 | CDK19 | 1.44990345 |
| 25 | PLK2 | 1.39711743 |
| 26 | PNCK | 1.38274159 |
| 27 | KSR1 | 1.37075691 |
| 28 | SIK2 | 1.30606579 |
| 29 | MAP3K2 | 1.29351006 |
| 30 | PRKCG | 1.24123622 |
| 31 | TYRO3 | 1.22422143 |
| 32 | PHKG1 | 1.16334965 |
| 33 | PHKG2 | 1.16334965 |
| 34 | UHMK1 | 1.16052449 |
| 35 | PINK1 | 1.13022512 |
| 36 | PRPF4B | 1.11945934 |
| 37 | LATS2 | 1.11525713 |
| 38 | TAOK1 | 1.10288264 |
| 39 | FES | 1.07588839 |
| 40 | LMTK2 | 1.05775921 |
| 41 | CASK | 1.05427976 |
| 42 | TNIK | 1.04253123 |
| 43 | MAPK13 | 1.03861346 |
| 44 | MAP3K13 | 1.03467804 |
| 45 | ALK | 1.01391421 |
| 46 | CAMK1 | 1.00566802 |
| 47 | MAP3K11 | 0.97796413 |
| 48 | STK11 | 0.97690704 |
| 49 | MAPK12 | 0.96615339 |
| 50 | CDK15 | 0.93945223 |
| 51 | RET | 0.93607006 |
| 52 | PRKCH | 0.93192404 |
| 53 | CDK18 | 0.93155243 |
| 54 | CAMK2A | 0.89992049 |
| 55 | SGK494 | 0.88952277 |
| 56 | SGK223 | 0.88952277 |
| 57 | CDK14 | 0.88821549 |
| 58 | NEK1 | 0.83926254 |
| 59 | CDK11A | 0.81934306 |
| 60 | SCYL2 | 0.76670257 |
| 61 | RAF1 | 0.73954988 |
| 62 | RIPK1 | 0.72906723 |
| 63 | PDK1 | 0.72673032 |
| 64 | PKN1 | 0.72590815 |
| 65 | SGK3 | 0.72283670 |
| 66 | PAK3 | 0.71901356 |
| 67 | BRAF | 0.71629411 |
| 68 | SGK2 | 0.71508360 |
| 69 | OXSR1 | 0.70041955 |
| 70 | PTK2B | 0.69729336 |
| 71 | LIMK1 | 0.69700137 |
| 72 | TESK1 | 0.68158170 |
| 73 | CAMK2B | 0.67937344 |
| 74 | PDPK1 | 0.66533972 |
| 75 | CSNK1G2 | 0.66284231 |
| 76 | MAP3K1 | 0.65706925 |
| 77 | TNK2 | 0.63577902 |
| 78 | SGK1 | 0.62020050 |
| 79 | WNK1 | 0.60317155 |
| 80 | BRSK1 | 0.58566737 |
| 81 | DYRK1A | 0.58433140 |
| 82 | MARK2 | 0.57485503 |
| 83 | CDC42BPA | 0.53274882 |
| 84 | RPS6KA3 | 0.50400732 |
| 85 | CAMK4 | 0.50225460 |
| 86 | CAMK2G | 0.49813137 |
| 87 | BMPR2 | 0.48047088 |
| 88 | DAPK3 | 0.47598048 |
| 89 | PRKCZ | 0.47548016 |
| 90 | CAMK2D | 0.46088614 |
| 91 | MAPK10 | 0.45721718 |
| 92 | CAMK1G | 0.45408556 |
| 93 | FYN | 0.43263533 |
| 94 | CCNB1 | 0.42484927 |
| 95 | PRKCE | 0.40769548 |
| 96 | MAP2K1 | 0.40263329 |
| 97 | MAP3K7 | 0.38547384 |
| 98 | FGFR2 | 0.38422723 |
| 99 | NEK6 | 0.37438634 |
| 100 | FER | 0.35573196 |
| 101 | MAPKAPK5 | 0.34856574 |
| 102 | PRKCA | 0.34691330 |
| 103 | MAP2K6 | 0.33510837 |
| 104 | MAP3K6 | 0.32743865 |
| 105 | NME1 | 0.32564374 |
| 106 | RPS6KA2 | 0.31519611 |
| 107 | PDK3 | 0.31285289 |
| 108 | PDK4 | 0.31285289 |
| 109 | FGR | 0.30430043 |
| 110 | ROCK2 | 0.29635913 |
| 111 | MAPK8 | 0.27411744 |
| 112 | MAPK4 | 0.26327999 |
| 113 | PRKG2 | 0.24292178 |
| 114 | SRC | 0.23552969 |
| 115 | ERBB2 | 0.23106930 |
| 116 | DYRK2 | 0.22780845 |
| 117 | PRKCB | 0.22377847 |
| 118 | PRKACA | 0.22153140 |
| 119 | ROCK1 | 0.21921467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.66789150 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.61122656 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.77040559 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71934300 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62645043 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.61945756 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59855002 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.53741983 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.49228853 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.41880157 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34593790 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19179047 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09888097 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.03954944 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96280565 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87436993 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83134621 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72466161 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.70896588 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.68748915 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62089807 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60746794 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60028112 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.58674975 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.54296449 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52766140 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51181150 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49923798 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46112557 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45787088 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43043943 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33574531 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.32279629 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29562854 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21631778 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21308372 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19406796 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.14226695 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.11725791 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10123121 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05131465 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99036261 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97892566 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.97824453 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95764822 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95318075 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.94804757 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.92114833 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90089762 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.87357649 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86327151 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86145695 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85273005 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83375306 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80909310 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77803228 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76777335 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73591803 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72507346 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66763793 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66021698 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65835596 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64813870 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62817276 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61678713 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.58797435 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57928441 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56537835 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.55749344 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55738710 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55386040 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53167287 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50379264 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47661612 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47413753 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47362957 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47233497 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46862530 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45941984 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45648653 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.44210868 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43347625 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43070756 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.42892023 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42548607 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41913304 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40884028 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40587903 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40332446 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40101932 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38727921 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36747482 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35814090 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35596373 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35432245 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34703762 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33533078 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29383407 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29305023 |
| 100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28773806 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28685602 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28516513 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28461165 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27238024 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26513146 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23534877 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23520768 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21253857 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18397854 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.12820324 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12733299 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.11548336 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.11315293 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10355629 |

